FSSAI Cracks Down on Misleading Rice Bran Oil Claims
The Food Safety and Standards Authority of India initiated enforcement against unverified rice bran oil claims in retail markets. Specifically, the regulator issued show-cause notices to Gemini Edibles and Fats India, BigBasket, and Flipkart. These notices highlight concerns regarding unsubstantiated cardiovascular assertions made for Freedom Cooking Rice Bran Oil. Consequently, clinicians and consumers must evaluate the scientific and regulatory validity of popular dietary oil promotions.
Details of the FSSAI Regulatory Action
The statutory authority flagged specific promotional assertions made on e-commerce channels and social media. In particular, marketers claimed that the product reduces bad cholesterol and maintains or increases good cholesterol. Furthermore, promotional campaigns prominently highlighted an oryzanol content exceeding 10,000 parts per million. However, the regulatory body determined that existing standards do not allow such explicit therapeutic statements for edible vegetable oils. In addition, FSSAI identified that Gemini Edibles operated an e-commerce platform without an appropriate central license. Therefore, the authority ordered all three entities to show cause under the Food Safety and Standards Act, 2006.
Regulatory Framework Governing Rice Bran Oil Claims
Under the Food Safety and Standards (Advertising and Claims) Regulations, 2018, commercial operators must substantiate all health declarations. Indeed, Schedule II-A outlines permitted representations for edible vegetable oils. While rice bran oil naturally contains gamma-oryzanol, manufacturers cannot market basic culinary oils as therapeutic drugs. Moreover, unregulated cholesterol-lowering assertions create unjustified clinical impressions among vulnerable patients. Consequently, regulatory vigilance ensures that commercial marketing does not supplant established medical guidance. The authority also took parallel enforcement steps against other food operators for sanitation and storage lapses. Thus, food businesses face increasing scrutiny across their manufacturing and marketing operations.
Clinical Implications for Cardiovascular Risk Management
Physicians frequently encounter patients who rely heavily on cooking oil marketing rather than structured medical therapy. Although rice bran oil provides monounsaturated and polyunsaturated fats, it remains an energy-dense lipid. Therefore, excessive intake can hinder weight management and aggravate metabolic dysfunction. Furthermore, substituting proven pharmacological interventions with marketed cooking oils elevates cardiovascular risk. Clinicians should educate individuals that no single edible oil can cure hypercholesterolemia. Instead, patients achieve optimal lipid control through comprehensive dietary modification, regular physical activity, and prescribed pharmacotherapy. Hence, clear regulatory oversight supports clinical efforts to promote evidence-based dietary habits.
Frequently Asked Questions
Q1: Why did FSSAI issue notices over rice bran oil claims?
FSSAI issued notices because promotional materials claimed the oil actively lowers bad cholesterol and elevates good cholesterol. These claims violate the Food Safety and Standards (Advertising and Claims) Regulations, 2018.
Q2: Does natural oryzanol in rice bran oil eliminate cardiovascular risk?
No, natural oryzanol does not cure cardiovascular disease. While research explores its antioxidant properties, consumers cannot treat cooking oil as a substitute for physician-directed lipid therapy.
Q3: Which platforms received show-cause notices from the regulator?
The regulator issued show-cause notices to Gemini Edibles & Fats India Ltd, along with major e-commerce platforms BigBasket and Flipkart.
References
- FSSAI issues notices to Gemini Edibles, BigBasket, Flipkart for misleadingclaims - ETHealthworld
- Food Safety and Standards Authority of India (FSSAI). Food Safety and Standards (Advertising and Claims) Regulations, 2018.
- The New Indian Express. FSSAI flags 'cholesterol-lowering' claims on rice bran oil, issues notices to BigBasket, Flipkart. October 16, 2026.
